NH Korindo Sekuritas Indonesia
Menu
  • Our Service
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
    • Equity
    • Fixed Income
    • Margin
    • Investment Banking
      • IPO
      • E-IPO
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • About Us
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • Contact
  • Register Now
  • ID
  • EN

ADRO – Modest Performance During the Pandemic

  • Author
  • Recent Posts
Maryoki Pajri
Maryoki Pajri
Analyst - Mining, Basic Ind., Agri.
Maryoki Pajri
Latest posts by Maryoki Pajri (see all)
  • PTBA – FY2020 Result Below Expectations - March 22, 2021
  • UNTR – Lower Sales Volume in 2020 - March 15, 2021
  • AALI – Higher ASP Boosts Performance - March 4, 2021

In 3Q20, ADRO recorded a modest performance with net loss of USD47 million or -180% QoQ (-142% YoY). Meanwhile, in 9M20 ADRO was able to booked bottom line of USD109 million or decreased 73% YoY. We revised our forecast for 2020-2022F to adjust with company and industry outlook. Thus, we revised our recommendation to OVERWEIGHT with Target Price at IDR1,580.

Download full report HERE.

Share This Article

Related Article


Company Report | [SIDO IJ] Continuing To Widen Bottom-Line Margin, Higher Overseas Revenue, And Expand Into Younger Consumer Bases

26 Mar 2025

FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth across all revenue segments Herbal and Supplements with 6% YoY; Food and Beverages (18% YoY); and Pharmaceutical (10% YoY).

Company Report | [CUAN] Acquisitions Bear Fruit, New Mine Commences

26 Mar 2025

Petrindo Jaya Kreasi (CUAN) reported an impressive 718.6% YoY rise in revenue (USD 801.7 M vs USD 97.9 M) and 929.3% increase in net income (USD 160.8 M vs USD 15.6 M) for FY24.

Company Report | [SMSS IJ] Shifting Towards Diversified CPO Derivative Products

17 Mar 2025

On a quarterly basis, 3Q24 sales declined by 19% QoQ (vs 2Q24’s 10% QoQ) as the Sales are usually weakest on the first and third quarter. In the fourth quarter, sales consistently shot up by historical evidence in 4Q23 & 4Q22 with 303% QoQ & 85% QoQ, respectively.

 

More Article

Daily Report

16 May 2025

Daily Report | 16 May 2025

The S&P 500 hovered near the flatline on Thursday, putting its three-day winning streak...

READ MORE

Daily Report

15 May 2025

Daily Report | 15 May 2025

The S&P 500 rose modestly on Wednesday, extending a strong start to the week that pushe...

READ MORE

Daily Report

14 May 2025

Daily Report | 14 May 2025

The S&P 500 rose Tuesday, clawing back into positive territory for the year, as investo...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia terdaftar dan diawasi oleh Otoritas Jasa Keuangan (OJK).


Copyright 2025 NH Korindo Sekuritas. All rights reserved.